He discusses news from Biogen and Regeneron, and shares his top picks Xenon, Soleno, and Lexeo.

Brian Skorney gives his take on biotech and discusses Sarepta, Lexeo, Gilead, Mirum, Amgen, Vertex, Neurocrine, and Applied Therapeutics.

Brian Skorney comments on the Ambrx and Harpoon acquisitions, the year ahead in biotech, and his top picks Biogen, Neurocrine, and Biohaven.

Brian Skorney discusses this week’s data from Neurocrine Biosciences and Crinetics, and comments on Amgen, Regeneron, and Arbutus.

Brian Skorney discusses biotech's first half of 2023 and recent news from Sarepta, Regeneron, AstraZeneca, Vertex, and Biogen.

R.W. Baird Senior Research Analyst Brian Skorney speaks first with BiotechTV on the Monday morning JPM23.